Search
deen

Legal Advice

Healthcare

The health­care sec­tor is a dy­na­mic, highly in­no­va­tive and ex­tre­mely im­port­ant branch of the eco­nomy. Ne­vert­he­less, it faces si­gni­fi­cant chal­len­ges, in­clu­ding the new awa­ren­ess of health among the ge­ne­ral pu­blic, an aging so­ciety, a lack of ju­nior staff, tight bud­gets and in­cre­asing de­mands as pro­gress is made in me­di­cal know­ledge. To re­main ef­fec­tive, the sec­tor must not only re­act, but also tackle these chal­len­ges proac­tively.

New op­por­tu­nities in the health­care sec­tor and con­stantly-chan­ging re­gu­la­ti­ons re­quire quick re­ac­tions by all play­ers in this sec­tor—from hos­pi­tals and out­pa­ti­ent ser­vice pro­vi­ders to nur­sing ho­mes. At RSM Eb­ner Stolz, we have the le­gal ex­per­tise in the health­care sec­tor you need in or­der to im­ple­ment so­lu­ti­ons quickly and ef­fec­tively, re­gard­less of the is­sue.

Our team of spe­cia­li­zed at­tor­neys as­sists and ad­vi­ses health­care fa­ci­li­ties (both on the ope­ra­tor's and on the in­ves­tor's side), ac­com­pa­nies start-ups and tran­sac­tions in the health­care and so­cial ser­vices sec­tor and of­fers pro­fes­sio­nal cri­sis ma­nage­ment in the event of ne­cessary re­or­ga­niza­ti­ons or re­struc­tu­rings, even in the event of in­sol­vency. We can also ad­vise you on how to im­ple­ment all com­pli­ance stan­dards.

Our services at a glance

  • Hos­pi­tal law (hos­pi­tal plan­ning and fi­nan­cing, ne­go­tia­ti­ons with in­surance com­pa­nies, cy­to­sta­tics)
  • Phy­si­cian law and con­tract phy­si­cian law (li­cen­sing, tran­sac­tions, health­care cen­ter li­cen­sing)
  • Nur­sing care and nur­sing home law
  • Te­le­me­di­cine
  • Cor­po­rate Fi­nance in health­care and so­cial ser­vices
  • Health­care and M&A
  • Re­or­ga­niza­tion, re­struc­tu­ring and in­sol­vency in the health­care and so­cial ser­vices sec­tors
  • New forms of care, mo­del pro­jects/area-wide and emer­gency care
  • Com­pli­ance law for health­care and so­cial ser­vices
back to top

Related Topics

RSM Eb­ner Stolz wins two large teams to build up le­gal ser­vices in Bonn

RSM Eb­ner Stolz has strengt­he­ned its le­gal arm with two teams around cor­po­rate re­struc­tu­ring ex­pert Dr. Pierre Gloz­bach and pu­blic pro­cu­re­ment law spe­cia­list Mar­tin Schumm, LL.M., ef­fec­tive Oc­to­ber 1, 2023. This marks the start of the as­surance and con­sul­ting firm's de­ve­lop­ment of a le­gal ad­vi­sory di­vi­sion at its Bonn of­fice af­ter joi­ning the RSM net­work and gi­ves it ac­cess to the stra­te­gi­cally im­port­ant areas of al­ter­na­tive le­gal ser­vices and le­gal ope­ra­ti­ons con­sul­ting, as well as pu­blic pro­cu­re­ment and state aid law con­sul­ting, among others.  ...read more

Indo-Ger­man M&A De­ve­lop­ment in 2022

Af­ter a tor­ren­tial re­cord-brea­king year of M&A ac­tivity in 2021, the deal ma­kers ap­pear to have step­ped off the ac­ce­le­ra­tor in the first half of 2022. The glo­bal M&A ac­tivi­ties, re­co­ve­ring from the CO­VID-19 pan­de­mic re­ached un­pre­ce­den­ted le­vels of USD 5.9 tril­lion in deal va­lues in 2021 ac­cor­ding to the ‘Glo­bal M&A Re­port Midyear 2022’ by Bain & Com­pany. Ac­cor­ding to the same re­port, the ag­gre­ga­ted glo­bal deal va­lues by the first half of 2022 re­du­ced by 20% com­pa­red to the pre­vious year but could still re­ach an ex­tra­po­la­ted va­lue of USD 4.7 tril­lion in deal va­lue by the end of 2022.  ...read more

Eb­ner Stolz sup­ports SYZ Ca­pi­tal and Sa­tur­nus Ca­pi­tal on the ac­qui­si­tion of a ma­jo­rity stake in SK Pharma Lo­gistics GmbH

The au­diting and con­sul­ting firm Eb­ner Stolz has sup­por­ted SYZ Ca­pi­tal and Sa­tur­nus Ca­pi­tal on the ac­qui­si­tion of SK Pharma Lo­gistics GmbH (SK Pharma) with a com­pre­hen­sive fi­nan­cial and tax due di­li­gence and, to­ge­ther with Swiss Ne­xia part­ner ADB Alt­dor­fer Duss & Beil­stein AG, with the tax struc­tu­ring of the tran­sac­tion.  ...read more

Study on In­dian-Ger­man cor­po­rate tran­sac­tions by Nex­digm and Eb­ner Stolz

While Ger­man in­ves­tors are fo­cu­sing on the growth po­ten­tial of the In­dian mar­ket, Ger­many is seen by In­dian com­pa­nies as a stra­te­gic lo­ca­tion in terms of in­fra­struc­ture, lo­gistics and re­se­arch and de­ve­lop­ment. The Nex­digm-Eb­ner Stolz study "Enab­ling Col­la­bo­ra­tive De­ve­lop­ment - Indo-Ger­man deals in a de­cade" high­lights tran­sac­tions in the Indo-Ger­man trade cor­ri­dor.  ...read more